nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—Etoposide—sarcoma	0.0407	0.357	CbGbCtD
Celecoxib—CYP3A4—Thiotepa—sarcoma	0.0297	0.26	CbGbCtD
Celecoxib—CYP3A4—Mitoxantrone—sarcoma	0.0128	0.112	CbGbCtD
Celecoxib—CYP3A4—Vincristine—sarcoma	0.00878	0.077	CbGbCtD
Celecoxib—CYP2D6—Doxorubicin—sarcoma	0.00863	0.0757	CbGbCtD
Celecoxib—PDPK1—mammary gland—sarcoma	0.00818	0.0528	CbGeAlD
Celecoxib—CYP3A4—Etoposide—sarcoma	0.00805	0.0705	CbGbCtD
Celecoxib—PDPK1—myometrium—sarcoma	0.0058	0.0375	CbGeAlD
Celecoxib—CA2—periosteum—sarcoma	0.00573	0.037	CbGeAlD
Celecoxib—PDPK1—embryo—sarcoma	0.00558	0.0361	CbGeAlD
Celecoxib—CYP3A4—Doxorubicin—sarcoma	0.00549	0.0481	CbGbCtD
Celecoxib—PDPK1—hematopoietic system—sarcoma	0.00498	0.0322	CbGeAlD
Celecoxib—PTGS2—periosteum—sarcoma	0.00423	0.0273	CbGeAlD
Celecoxib—PDPK1—uterus—sarcoma	0.00376	0.0243	CbGeAlD
Celecoxib—PDPK1—lymphoid tissue—sarcoma	0.00351	0.0227	CbGeAlD
Celecoxib—PTGS2—leg—sarcoma	0.00337	0.0218	CbGeAlD
Celecoxib—PTGS2—hindlimb—sarcoma	0.00301	0.0195	CbGeAlD
Celecoxib—MAPK14—embryo—sarcoma	0.00298	0.0193	CbGeAlD
Celecoxib—CA5B—mammary gland—sarcoma	0.00298	0.0192	CbGeAlD
Celecoxib—PTGS2—cartilage tissue—sarcoma	0.00297	0.0192	CbGeAlD
Celecoxib—PDPK1—testis—sarcoma	0.00273	0.0176	CbGeAlD
Celecoxib—CA14—seminal vesicle—sarcoma	0.00273	0.0176	CbGeAlD
Celecoxib—MAPK14—hematopoietic system—sarcoma	0.00266	0.0172	CbGeAlD
Celecoxib—PTGS2—appendage—sarcoma	0.00258	0.0167	CbGeAlD
Celecoxib—PDPK1—liver—sarcoma	0.00258	0.0167	CbGeAlD
Celecoxib—MAPK14—connective tissue—sarcoma	0.00257	0.0166	CbGeAlD
Celecoxib—CA5A—liver—sarcoma	0.00242	0.0157	CbGeAlD
Celecoxib—MAPK14—smooth muscle tissue—sarcoma	0.00235	0.0152	CbGeAlD
Celecoxib—MAPK14—skin of body—sarcoma	0.00232	0.015	CbGeAlD
Celecoxib—ALB—mammary gland—sarcoma	0.00231	0.0149	CbGeAlD
Celecoxib—MAPK14—uterus—sarcoma	0.00201	0.013	CbGeAlD
Celecoxib—PDPK1—lymph node—sarcoma	0.00198	0.0128	CbGeAlD
Celecoxib—CA14—cardiac atrium—sarcoma	0.00197	0.0127	CbGeAlD
Celecoxib—CA12—connective tissue—sarcoma	0.00195	0.0126	CbGeAlD
Celecoxib—MAPK14—lymphoid tissue—sarcoma	0.00188	0.0121	CbGeAlD
Celecoxib—CA5B—hematopoietic system—sarcoma	0.00181	0.0117	CbGeAlD
Celecoxib—CA9—tendon—sarcoma	0.00181	0.0117	CbGeAlD
Celecoxib—MAPK14—tendon—sarcoma	0.00176	0.0114	CbGeAlD
Celecoxib—CA14—tendon—sarcoma	0.00172	0.0111	CbGeAlD
Celecoxib—MAPK14—bone marrow—sarcoma	0.00171	0.011	CbGeAlD
Celecoxib—ORM1—hematopoietic system—sarcoma	0.0016	0.0104	CbGeAlD
Celecoxib—PTGS2—endothelium—sarcoma	0.00156	0.0101	CbGeAlD
Celecoxib—CA9—testis—sarcoma	0.0015	0.00967	CbGeAlD
Celecoxib—MAPK14—testis—sarcoma	0.00146	0.00943	CbGeAlD
Celecoxib—CYP2C9—mammary gland—sarcoma	0.00144	0.00931	CbGeAlD
Celecoxib—MAPK14—liver—sarcoma	0.00138	0.00892	CbGeAlD
Celecoxib—CA5B—cardiac atrium—sarcoma	0.00138	0.0089	CbGeAlD
Celecoxib—ABCC4—hematopoietic system—sarcoma	0.00136	0.0088	CbGeAlD
Celecoxib—CA14—liver—sarcoma	0.00134	0.00868	CbGeAlD
Celecoxib—CA4—seminal vesicle—sarcoma	0.00132	0.00851	CbGeAlD
Celecoxib—CA5B—tendon—sarcoma	0.0012	0.00775	CbGeAlD
Celecoxib—CA2—embryo—sarcoma	0.00116	0.00751	CbGeAlD
Celecoxib—CA2—seminal vesicle—sarcoma	0.00109	0.00705	CbGeAlD
Celecoxib—MAPK14—lymph node—sarcoma	0.00106	0.00684	CbGeAlD
Celecoxib—CA2—hematopoietic system—sarcoma	0.00104	0.0067	CbGeAlD
Celecoxib—ABCC4—uterus—sarcoma	0.00103	0.00664	CbGeAlD
Celecoxib—ORM1—bone marrow—sarcoma	0.00103	0.00664	CbGeAlD
Celecoxib—CA2—connective tissue—sarcoma	0.000999	0.00646	CbGeAlD
Celecoxib—CA5B—testis—sarcoma	0.000994	0.00642	CbGeAlD
Celecoxib—CA4—cardiac atrium—sarcoma	0.00095	0.00614	CbGeAlD
Celecoxib—CA2—smooth muscle tissue—sarcoma	0.000914	0.00591	CbGeAlD
Celecoxib—CA2—skin of body—sarcoma	0.000902	0.00583	CbGeAlD
Celecoxib—ABCC4—tendon—sarcoma	0.000901	0.00582	CbGeAlD
Celecoxib—PTGS2—myometrium—sarcoma	0.000892	0.00576	CbGeAlD
Celecoxib—CYP2C9—hematopoietic system—sarcoma	0.000878	0.00567	CbGeAlD
Celecoxib—ABCC4—bone marrow—sarcoma	0.000873	0.00564	CbGeAlD
Celecoxib—PTGS2—embryo—sarcoma	0.000858	0.00554	CbGeAlD
Celecoxib—ORM1—liver—sarcoma	0.000831	0.00537	CbGeAlD
Celecoxib—CA4—tendon—sarcoma	0.000828	0.00535	CbGeAlD
Celecoxib—PTGS2—seminal vesicle—sarcoma	0.000806	0.00521	CbGeAlD
Celecoxib—CA4—bone marrow—sarcoma	0.000802	0.00518	CbGeAlD
Celecoxib—CA2—cardiac atrium—sarcoma	0.000788	0.00509	CbGeAlD
Celecoxib—ALB—testis—sarcoma	0.000771	0.00498	CbGeAlD
Celecoxib—PTGS2—hematopoietic system—sarcoma	0.000766	0.00495	CbGeAlD
Celecoxib—ABCC4—testis—sarcoma	0.000746	0.00482	CbGeAlD
Celecoxib—PTGS2—connective tissue—sarcoma	0.000738	0.00477	CbGeAlD
Celecoxib—CA2—lymphoid tissue—sarcoma	0.000731	0.00472	CbGeAlD
Celecoxib—ALB—liver—sarcoma	0.000729	0.00471	CbGeAlD
Celecoxib—CA5B—lymph node—sarcoma	0.00072	0.00465	CbGeAlD
Celecoxib—ABCC4—liver—sarcoma	0.000705	0.00456	CbGeAlD
Celecoxib—CA2—tendon—sarcoma	0.000687	0.00444	CbGeAlD
Celecoxib—CA4—testis—sarcoma	0.000686	0.00443	CbGeAlD
Celecoxib—PTGS2—smooth muscle tissue—sarcoma	0.000675	0.00436	CbGeAlD
Celecoxib—CYP3A4—hematopoietic system—sarcoma	0.00067	0.00433	CbGeAlD
Celecoxib—PTGS2—skin of body—sarcoma	0.000666	0.0043	CbGeAlD
Celecoxib—CA2—bone marrow—sarcoma	0.000665	0.0043	CbGeAlD
Celecoxib—CYP2D6—hematopoietic system—sarcoma	0.000659	0.00426	CbGeAlD
Celecoxib—ORM1—lymph node—sarcoma	0.000637	0.00412	CbGeAlD
Celecoxib—PTGS2—uterus—sarcoma	0.000579	0.00374	CbGeAlD
Celecoxib—CA2—testis—sarcoma	0.000569	0.00367	CbGeAlD
Celecoxib—ALB—lymph node—sarcoma	0.000559	0.00361	CbGeAlD
Celecoxib—ABCC4—lymph node—sarcoma	0.000541	0.00349	CbGeAlD
Celecoxib—PTGS2—lymphoid tissue—sarcoma	0.000539	0.00348	CbGeAlD
Celecoxib—CA2—liver—sarcoma	0.000538	0.00347	CbGeAlD
Celecoxib—PTGS2—tendon—sarcoma	0.000507	0.00328	CbGeAlD
Celecoxib—CA4—lymph node—sarcoma	0.000497	0.00321	CbGeAlD
Celecoxib—PTGS2—bone marrow—sarcoma	0.000491	0.00317	CbGeAlD
Celecoxib—CYP2C9—liver—sarcoma	0.000455	0.00294	CbGeAlD
Celecoxib—CA2—lymph node—sarcoma	0.000412	0.00266	CbGeAlD
Celecoxib—PTGS2—liver—sarcoma	0.000397	0.00256	CbGeAlD
Celecoxib—CYP2D6—testis—sarcoma	0.000361	0.00233	CbGeAlD
Celecoxib—CYP3A4—liver—sarcoma	0.000347	0.00224	CbGeAlD
Celecoxib—CYP2D6—liver—sarcoma	0.000341	0.00221	CbGeAlD
Celecoxib—PTGS2—lymph node—sarcoma	0.000304	0.00197	CbGeAlD
Celecoxib—Dysuria—Epirubicin—sarcoma	0.000275	0.000759	CcSEcCtD
Celecoxib—Dizziness—Thiotepa—sarcoma	0.000274	0.000758	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Epirubicin—sarcoma	0.000273	0.000755	CcSEcCtD
Celecoxib—Dysphagia—Doxorubicin—sarcoma	0.000272	0.000751	CcSEcCtD
Celecoxib—Pollakiuria—Epirubicin—sarcoma	0.000271	0.00075	CcSEcCtD
Celecoxib—Hypersensitivity—Vincristine—sarcoma	0.000271	0.000749	CcSEcCtD
Celecoxib—Eosinophilia—Doxorubicin—sarcoma	0.000269	0.000744	CcSEcCtD
Celecoxib—Photosensitivity reaction—Epirubicin—sarcoma	0.000268	0.000741	CcSEcCtD
Celecoxib—Paraesthesia—Etoposide—sarcoma	0.000268	0.00074	CcSEcCtD
Celecoxib—Weight increased—Epirubicin—sarcoma	0.000267	0.000739	CcSEcCtD
Celecoxib—Pancreatitis—Doxorubicin—sarcoma	0.000267	0.000737	CcSEcCtD
Celecoxib—Dyspnoea—Etoposide—sarcoma	0.000266	0.000734	CcSEcCtD
Celecoxib—Hyperglycaemia—Epirubicin—sarcoma	0.000265	0.000733	CcSEcCtD
Celecoxib—Somnolence—Etoposide—sarcoma	0.000265	0.000732	CcSEcCtD
Celecoxib—Angina pectoris—Doxorubicin—sarcoma	0.000265	0.000732	CcSEcCtD
Celecoxib—Hypersensitivity—Mitoxantrone—sarcoma	0.000264	0.00073	CcSEcCtD
Celecoxib—Asthenia—Vincristine—sarcoma	0.000264	0.00073	CcSEcCtD
Celecoxib—Vomiting—Thiotepa—sarcoma	0.000264	0.000729	CcSEcCtD
Celecoxib—Pneumonia—Epirubicin—sarcoma	0.000264	0.000728	CcSEcCtD
Celecoxib—Infestation NOS—Epirubicin—sarcoma	0.000262	0.000724	CcSEcCtD
Celecoxib—Infestation—Epirubicin—sarcoma	0.000262	0.000724	CcSEcCtD
Celecoxib—Vomiting—Dactinomycin—sarcoma	0.000262	0.000724	CcSEcCtD
Celecoxib—Rash—Thiotepa—sarcoma	0.000262	0.000723	CcSEcCtD
Celecoxib—Bronchitis—Doxorubicin—sarcoma	0.000261	0.000723	CcSEcCtD
Celecoxib—Dermatitis—Thiotepa—sarcoma	0.000261	0.000722	CcSEcCtD
Celecoxib—Headache—Thiotepa—sarcoma	0.00026	0.000718	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00026	0.000718	CcSEcCtD
Celecoxib—Rash—Dactinomycin—sarcoma	0.00026	0.000718	CcSEcCtD
Celecoxib—Decreased appetite—Etoposide—sarcoma	0.000259	0.000716	CcSEcCtD
Celecoxib—Pancytopenia—Doxorubicin—sarcoma	0.000258	0.000714	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Etoposide—sarcoma	0.000257	0.000711	CcSEcCtD
Celecoxib—Asthenia—Mitoxantrone—sarcoma	0.000257	0.000711	CcSEcCtD
Celecoxib—Fatigue—Etoposide—sarcoma	0.000257	0.00071	CcSEcCtD
Celecoxib—Neuropathy peripheral—Epirubicin—sarcoma	0.000257	0.00071	CcSEcCtD
Celecoxib—Stomatitis—Epirubicin—sarcoma	0.000255	0.000706	CcSEcCtD
Celecoxib—Jaundice—Epirubicin—sarcoma	0.000255	0.000706	CcSEcCtD
Celecoxib—Constipation—Etoposide—sarcoma	0.000255	0.000704	CcSEcCtD
Celecoxib—Conjunctivitis—Epirubicin—sarcoma	0.000255	0.000704	CcSEcCtD
Celecoxib—Urinary tract infection—Epirubicin—sarcoma	0.000255	0.000704	CcSEcCtD
Celecoxib—Dysuria—Doxorubicin—sarcoma	0.000254	0.000703	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000253	0.000698	CcSEcCtD
Celecoxib—Diarrhoea—Vincristine—sarcoma	0.000252	0.000696	CcSEcCtD
Celecoxib—Pollakiuria—Doxorubicin—sarcoma	0.000251	0.000694	CcSEcCtD
Celecoxib—Haematuria—Epirubicin—sarcoma	0.00025	0.00069	CcSEcCtD
Celecoxib—Photosensitivity reaction—Doxorubicin—sarcoma	0.000248	0.000686	CcSEcCtD
Celecoxib—Hepatobiliary disease—Epirubicin—sarcoma	0.000248	0.000685	CcSEcCtD
Celecoxib—Weight increased—Doxorubicin—sarcoma	0.000247	0.000684	CcSEcCtD
Celecoxib—Epistaxis—Epirubicin—sarcoma	0.000247	0.000683	CcSEcCtD
Celecoxib—Nausea—Thiotepa—sarcoma	0.000247	0.000681	CcSEcCtD
Celecoxib—Sinusitis—Epirubicin—sarcoma	0.000246	0.000679	CcSEcCtD
Celecoxib—Feeling abnormal—Etoposide—sarcoma	0.000246	0.000679	CcSEcCtD
Celecoxib—Hyperglycaemia—Doxorubicin—sarcoma	0.000245	0.000678	CcSEcCtD
Celecoxib—Diarrhoea—Mitoxantrone—sarcoma	0.000245	0.000678	CcSEcCtD
Celecoxib—Nausea—Dactinomycin—sarcoma	0.000245	0.000676	CcSEcCtD
Celecoxib—Agranulocytosis—Epirubicin—sarcoma	0.000245	0.000676	CcSEcCtD
Celecoxib—Pneumonia—Doxorubicin—sarcoma	0.000244	0.000674	CcSEcCtD
Celecoxib—Gastrointestinal pain—Etoposide—sarcoma	0.000244	0.000674	CcSEcCtD
Celecoxib—Dizziness—Vincristine—sarcoma	0.000243	0.000672	CcSEcCtD
Celecoxib—Infestation NOS—Doxorubicin—sarcoma	0.000242	0.00067	CcSEcCtD
Celecoxib—Infestation—Doxorubicin—sarcoma	0.000242	0.00067	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00024	0.000664	CcSEcCtD
Celecoxib—Neuropathy peripheral—Doxorubicin—sarcoma	0.000238	0.000657	CcSEcCtD
Celecoxib—Urticaria—Etoposide—sarcoma	0.000237	0.000654	CcSEcCtD
Celecoxib—Haemoglobin—Epirubicin—sarcoma	0.000236	0.000653	CcSEcCtD
Celecoxib—Jaundice—Doxorubicin—sarcoma	0.000236	0.000653	CcSEcCtD
Celecoxib—Stomatitis—Doxorubicin—sarcoma	0.000236	0.000653	CcSEcCtD
Celecoxib—Rhinitis—Epirubicin—sarcoma	0.000236	0.000652	CcSEcCtD
Celecoxib—Body temperature increased—Etoposide—sarcoma	0.000236	0.000651	CcSEcCtD
Celecoxib—Abdominal pain—Etoposide—sarcoma	0.000236	0.000651	CcSEcCtD
Celecoxib—Conjunctivitis—Doxorubicin—sarcoma	0.000236	0.000651	CcSEcCtD
Celecoxib—Urinary tract infection—Doxorubicin—sarcoma	0.000236	0.000651	CcSEcCtD
Celecoxib—Haemorrhage—Epirubicin—sarcoma	0.000235	0.00065	CcSEcCtD
Celecoxib—Hepatitis—Epirubicin—sarcoma	0.000235	0.00065	CcSEcCtD
Celecoxib—Hypoaesthesia—Epirubicin—sarcoma	0.000234	0.000647	CcSEcCtD
Celecoxib—Vomiting—Vincristine—sarcoma	0.000234	0.000647	CcSEcCtD
Celecoxib—Pharyngitis—Epirubicin—sarcoma	0.000233	0.000645	CcSEcCtD
Celecoxib—Urinary tract disorder—Epirubicin—sarcoma	0.000232	0.000642	CcSEcCtD
Celecoxib—Rash—Vincristine—sarcoma	0.000232	0.000641	CcSEcCtD
Celecoxib—Dermatitis—Vincristine—sarcoma	0.000232	0.000641	CcSEcCtD
Celecoxib—Oedema peripheral—Epirubicin—sarcoma	0.000232	0.00064	CcSEcCtD
Celecoxib—Haematuria—Doxorubicin—sarcoma	0.000231	0.000639	CcSEcCtD
Celecoxib—Connective tissue disorder—Epirubicin—sarcoma	0.000231	0.000639	CcSEcCtD
Celecoxib—Urethral disorder—Epirubicin—sarcoma	0.000231	0.000637	CcSEcCtD
Celecoxib—Headache—Vincristine—sarcoma	0.000231	0.000637	CcSEcCtD
Celecoxib—Hepatobiliary disease—Doxorubicin—sarcoma	0.000229	0.000634	CcSEcCtD
Celecoxib—Epistaxis—Doxorubicin—sarcoma	0.000229	0.000632	CcSEcCtD
Celecoxib—Vomiting—Mitoxantrone—sarcoma	0.000228	0.00063	CcSEcCtD
Celecoxib—Sinusitis—Doxorubicin—sarcoma	0.000227	0.000629	CcSEcCtD
Celecoxib—Agranulocytosis—Doxorubicin—sarcoma	0.000226	0.000625	CcSEcCtD
Celecoxib—Rash—Mitoxantrone—sarcoma	0.000226	0.000624	CcSEcCtD
Celecoxib—Dermatitis—Mitoxantrone—sarcoma	0.000226	0.000624	CcSEcCtD
Celecoxib—Headache—Mitoxantrone—sarcoma	0.000225	0.00062	CcSEcCtD
Celecoxib—Erythema multiforme—Epirubicin—sarcoma	0.000222	0.000615	CcSEcCtD
Celecoxib—Eye disorder—Epirubicin—sarcoma	0.00022	0.000607	CcSEcCtD
Celecoxib—Hypersensitivity—Etoposide—sarcoma	0.00022	0.000607	CcSEcCtD
Celecoxib—Tinnitus—Epirubicin—sarcoma	0.000219	0.000606	CcSEcCtD
Celecoxib—Haemoglobin—Doxorubicin—sarcoma	0.000219	0.000604	CcSEcCtD
Celecoxib—Nausea—Vincristine—sarcoma	0.000219	0.000604	CcSEcCtD
Celecoxib—Cardiac disorder—Epirubicin—sarcoma	0.000218	0.000603	CcSEcCtD
Celecoxib—Flushing—Epirubicin—sarcoma	0.000218	0.000603	CcSEcCtD
Celecoxib—Rhinitis—Doxorubicin—sarcoma	0.000218	0.000603	CcSEcCtD
Celecoxib—Haemorrhage—Doxorubicin—sarcoma	0.000218	0.000601	CcSEcCtD
Celecoxib—Hepatitis—Doxorubicin—sarcoma	0.000218	0.000601	CcSEcCtD
Celecoxib—Hypoaesthesia—Doxorubicin—sarcoma	0.000217	0.000598	CcSEcCtD
Celecoxib—Pharyngitis—Doxorubicin—sarcoma	0.000216	0.000597	CcSEcCtD
Celecoxib—Urinary tract disorder—Doxorubicin—sarcoma	0.000215	0.000594	CcSEcCtD
Celecoxib—Oedema peripheral—Doxorubicin—sarcoma	0.000214	0.000592	CcSEcCtD
Celecoxib—Asthenia—Etoposide—sarcoma	0.000214	0.000591	CcSEcCtD
Celecoxib—Connective tissue disorder—Doxorubicin—sarcoma	0.000214	0.000591	CcSEcCtD
Celecoxib—Angiopathy—Epirubicin—sarcoma	0.000213	0.00059	CcSEcCtD
Celecoxib—Urethral disorder—Doxorubicin—sarcoma	0.000213	0.00059	CcSEcCtD
Celecoxib—Nausea—Mitoxantrone—sarcoma	0.000213	0.000588	CcSEcCtD
Celecoxib—Immune system disorder—Epirubicin—sarcoma	0.000212	0.000587	CcSEcCtD
Celecoxib—Mediastinal disorder—Epirubicin—sarcoma	0.000212	0.000586	CcSEcCtD
Celecoxib—Pruritus—Etoposide—sarcoma	0.000211	0.000583	CcSEcCtD
Celecoxib—Arrhythmia—Epirubicin—sarcoma	0.00021	0.000581	CcSEcCtD
Celecoxib—Alopecia—Epirubicin—sarcoma	0.000208	0.000574	CcSEcCtD
Celecoxib—Mental disorder—Epirubicin—sarcoma	0.000206	0.000569	CcSEcCtD
Celecoxib—Erythema multiforme—Doxorubicin—sarcoma	0.000206	0.000569	CcSEcCtD
Celecoxib—Diarrhoea—Etoposide—sarcoma	0.000204	0.000564	CcSEcCtD
Celecoxib—Eye disorder—Doxorubicin—sarcoma	0.000203	0.000562	CcSEcCtD
Celecoxib—Tinnitus—Doxorubicin—sarcoma	0.000203	0.000561	CcSEcCtD
Celecoxib—Cardiac disorder—Doxorubicin—sarcoma	0.000202	0.000558	CcSEcCtD
Celecoxib—Flushing—Doxorubicin—sarcoma	0.000202	0.000558	CcSEcCtD
Celecoxib—Flatulence—Epirubicin—sarcoma	0.000202	0.000558	CcSEcCtD
Celecoxib—Tension—Epirubicin—sarcoma	0.000201	0.000555	CcSEcCtD
Celecoxib—Dysgeusia—Epirubicin—sarcoma	0.000201	0.000554	CcSEcCtD
Celecoxib—Nervousness—Epirubicin—sarcoma	0.000199	0.00055	CcSEcCtD
Celecoxib—Back pain—Epirubicin—sarcoma	0.000198	0.000547	CcSEcCtD
Celecoxib—Angiopathy—Doxorubicin—sarcoma	0.000197	0.000546	CcSEcCtD
Celecoxib—Dizziness—Etoposide—sarcoma	0.000197	0.000545	CcSEcCtD
Celecoxib—Muscle spasms—Epirubicin—sarcoma	0.000197	0.000544	CcSEcCtD
Celecoxib—Immune system disorder—Doxorubicin—sarcoma	0.000197	0.000543	CcSEcCtD
Celecoxib—Mediastinal disorder—Doxorubicin—sarcoma	0.000196	0.000542	CcSEcCtD
Celecoxib—Arrhythmia—Doxorubicin—sarcoma	0.000194	0.000537	CcSEcCtD
Celecoxib—Vision blurred—Epirubicin—sarcoma	0.000193	0.000533	CcSEcCtD
Celecoxib—Alopecia—Doxorubicin—sarcoma	0.000192	0.000531	CcSEcCtD
Celecoxib—Mental disorder—Doxorubicin—sarcoma	0.000191	0.000527	CcSEcCtD
Celecoxib—Vomiting—Etoposide—sarcoma	0.00019	0.000524	CcSEcCtD
Celecoxib—Anaemia—Epirubicin—sarcoma	0.000189	0.000523	CcSEcCtD
Celecoxib—Rash—Etoposide—sarcoma	0.000188	0.000519	CcSEcCtD
Celecoxib—Dermatitis—Etoposide—sarcoma	0.000188	0.000519	CcSEcCtD
Celecoxib—Headache—Etoposide—sarcoma	0.000187	0.000516	CcSEcCtD
Celecoxib—Flatulence—Doxorubicin—sarcoma	0.000187	0.000516	CcSEcCtD
Celecoxib—Tension—Doxorubicin—sarcoma	0.000186	0.000514	CcSEcCtD
Celecoxib—Dysgeusia—Doxorubicin—sarcoma	0.000186	0.000513	CcSEcCtD
Celecoxib—Nervousness—Doxorubicin—sarcoma	0.000184	0.000508	CcSEcCtD
Celecoxib—Vertigo—Epirubicin—sarcoma	0.000184	0.000508	CcSEcCtD
Celecoxib—Syncope—Epirubicin—sarcoma	0.000184	0.000507	CcSEcCtD
Celecoxib—Leukopenia—Epirubicin—sarcoma	0.000183	0.000506	CcSEcCtD
Celecoxib—Back pain—Doxorubicin—sarcoma	0.000183	0.000506	CcSEcCtD
Celecoxib—Muscle spasms—Doxorubicin—sarcoma	0.000182	0.000503	CcSEcCtD
Celecoxib—Palpitations—Epirubicin—sarcoma	0.000181	0.0005	CcSEcCtD
Celecoxib—Loss of consciousness—Epirubicin—sarcoma	0.00018	0.000497	CcSEcCtD
Celecoxib—Cough—Epirubicin—sarcoma	0.000179	0.000494	CcSEcCtD
Celecoxib—Vision blurred—Doxorubicin—sarcoma	0.000179	0.000493	CcSEcCtD
Celecoxib—Nausea—Etoposide—sarcoma	0.000177	0.000489	CcSEcCtD
Celecoxib—Hypertension—Epirubicin—sarcoma	0.000177	0.000488	CcSEcCtD
Celecoxib—Anaemia—Doxorubicin—sarcoma	0.000175	0.000484	CcSEcCtD
Celecoxib—Chest pain—Epirubicin—sarcoma	0.000174	0.000482	CcSEcCtD
Celecoxib—Arthralgia—Epirubicin—sarcoma	0.000174	0.000482	CcSEcCtD
Celecoxib—Myalgia—Epirubicin—sarcoma	0.000174	0.000482	CcSEcCtD
Celecoxib—Anxiety—Epirubicin—sarcoma	0.000174	0.00048	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000173	0.000478	CcSEcCtD
Celecoxib—Dry mouth—Epirubicin—sarcoma	0.00017	0.000471	CcSEcCtD
Celecoxib—Vertigo—Doxorubicin—sarcoma	0.00017	0.00047	CcSEcCtD
Celecoxib—Syncope—Doxorubicin—sarcoma	0.00017	0.000469	CcSEcCtD
Celecoxib—Leukopenia—Doxorubicin—sarcoma	0.00017	0.000469	CcSEcCtD
Celecoxib—Confusional state—Epirubicin—sarcoma	0.000168	0.000466	CcSEcCtD
Celecoxib—Palpitations—Doxorubicin—sarcoma	0.000167	0.000463	CcSEcCtD
Celecoxib—Oedema—Epirubicin—sarcoma	0.000167	0.000462	CcSEcCtD
Celecoxib—Anaphylactic shock—Epirubicin—sarcoma	0.000167	0.000462	CcSEcCtD
Celecoxib—Loss of consciousness—Doxorubicin—sarcoma	0.000167	0.00046	CcSEcCtD
Celecoxib—Infection—Epirubicin—sarcoma	0.000166	0.000459	CcSEcCtD
Celecoxib—Cough—Doxorubicin—sarcoma	0.000165	0.000457	CcSEcCtD
Celecoxib—Shock—Epirubicin—sarcoma	0.000164	0.000454	CcSEcCtD
Celecoxib—Nervous system disorder—Epirubicin—sarcoma	0.000164	0.000453	CcSEcCtD
Celecoxib—Thrombocytopenia—Epirubicin—sarcoma	0.000164	0.000452	CcSEcCtD
Celecoxib—Hypertension—Doxorubicin—sarcoma	0.000164	0.000452	CcSEcCtD
Celecoxib—Tachycardia—Epirubicin—sarcoma	0.000163	0.000451	CcSEcCtD
Celecoxib—Skin disorder—Epirubicin—sarcoma	0.000162	0.000449	CcSEcCtD
Celecoxib—Hyperhidrosis—Epirubicin—sarcoma	0.000162	0.000446	CcSEcCtD
Celecoxib—Myalgia—Doxorubicin—sarcoma	0.000161	0.000446	CcSEcCtD
Celecoxib—Arthralgia—Doxorubicin—sarcoma	0.000161	0.000446	CcSEcCtD
Celecoxib—Chest pain—Doxorubicin—sarcoma	0.000161	0.000446	CcSEcCtD
Celecoxib—Anxiety—Doxorubicin—sarcoma	0.000161	0.000444	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00016	0.000443	CcSEcCtD
Celecoxib—Anorexia—Epirubicin—sarcoma	0.000159	0.00044	CcSEcCtD
Celecoxib—Dry mouth—Doxorubicin—sarcoma	0.000158	0.000436	CcSEcCtD
Celecoxib—Confusional state—Doxorubicin—sarcoma	0.000156	0.000431	CcSEcCtD
Celecoxib—Oedema—Doxorubicin—sarcoma	0.000155	0.000427	CcSEcCtD
Celecoxib—Anaphylactic shock—Doxorubicin—sarcoma	0.000155	0.000427	CcSEcCtD
Celecoxib—Infection—Doxorubicin—sarcoma	0.000154	0.000424	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000152	0.000421	CcSEcCtD
Celecoxib—Shock—Doxorubicin—sarcoma	0.000152	0.00042	CcSEcCtD
Celecoxib—Nervous system disorder—Doxorubicin—sarcoma	0.000152	0.000419	CcSEcCtD
Celecoxib—Thrombocytopenia—Doxorubicin—sarcoma	0.000151	0.000418	CcSEcCtD
Celecoxib—Insomnia—Epirubicin—sarcoma	0.000151	0.000418	CcSEcCtD
Celecoxib—Tachycardia—Doxorubicin—sarcoma	0.000151	0.000417	CcSEcCtD
Celecoxib—Skin disorder—Doxorubicin—sarcoma	0.00015	0.000415	CcSEcCtD
Celecoxib—Paraesthesia—Epirubicin—sarcoma	0.00015	0.000415	CcSEcCtD
Celecoxib—Hyperhidrosis—Doxorubicin—sarcoma	0.000149	0.000413	CcSEcCtD
Celecoxib—Dyspnoea—Epirubicin—sarcoma	0.000149	0.000412	CcSEcCtD
Celecoxib—Somnolence—Epirubicin—sarcoma	0.000149	0.000411	CcSEcCtD
Celecoxib—Anorexia—Doxorubicin—sarcoma	0.000147	0.000407	CcSEcCtD
Celecoxib—Dyspepsia—Epirubicin—sarcoma	0.000147	0.000406	CcSEcCtD
Celecoxib—Decreased appetite—Epirubicin—sarcoma	0.000145	0.000401	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Epirubicin—sarcoma	0.000144	0.000399	CcSEcCtD
Celecoxib—Fatigue—Epirubicin—sarcoma	0.000144	0.000398	CcSEcCtD
Celecoxib—Constipation—Epirubicin—sarcoma	0.000143	0.000395	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000141	0.000389	CcSEcCtD
Celecoxib—Insomnia—Doxorubicin—sarcoma	0.00014	0.000386	CcSEcCtD
Celecoxib—Paraesthesia—Doxorubicin—sarcoma	0.000139	0.000384	CcSEcCtD
Celecoxib—Dyspnoea—Doxorubicin—sarcoma	0.000138	0.000381	CcSEcCtD
Celecoxib—Feeling abnormal—Epirubicin—sarcoma	0.000138	0.000381	CcSEcCtD
Celecoxib—Somnolence—Doxorubicin—sarcoma	0.000137	0.00038	CcSEcCtD
Celecoxib—Gastrointestinal pain—Epirubicin—sarcoma	0.000137	0.000378	CcSEcCtD
Celecoxib—Dyspepsia—Doxorubicin—sarcoma	0.000136	0.000376	CcSEcCtD
Celecoxib—Decreased appetite—Doxorubicin—sarcoma	0.000134	0.000371	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000133	0.000369	CcSEcCtD
Celecoxib—Fatigue—Doxorubicin—sarcoma	0.000133	0.000368	CcSEcCtD
Celecoxib—Urticaria—Epirubicin—sarcoma	0.000133	0.000367	CcSEcCtD
Celecoxib—Constipation—Doxorubicin—sarcoma	0.000132	0.000365	CcSEcCtD
Celecoxib—Abdominal pain—Epirubicin—sarcoma	0.000132	0.000365	CcSEcCtD
Celecoxib—Body temperature increased—Epirubicin—sarcoma	0.000132	0.000365	CcSEcCtD
Celecoxib—Feeling abnormal—Doxorubicin—sarcoma	0.000127	0.000352	CcSEcCtD
Celecoxib—Gastrointestinal pain—Doxorubicin—sarcoma	0.000126	0.000349	CcSEcCtD
Celecoxib—Hypersensitivity—Epirubicin—sarcoma	0.000123	0.00034	CcSEcCtD
Celecoxib—Urticaria—Doxorubicin—sarcoma	0.000123	0.000339	CcSEcCtD
Celecoxib—Body temperature increased—Doxorubicin—sarcoma	0.000122	0.000338	CcSEcCtD
Celecoxib—Abdominal pain—Doxorubicin—sarcoma	0.000122	0.000338	CcSEcCtD
Celecoxib—Asthenia—Epirubicin—sarcoma	0.00012	0.000331	CcSEcCtD
Celecoxib—Pruritus—Epirubicin—sarcoma	0.000118	0.000327	CcSEcCtD
Celecoxib—Diarrhoea—Epirubicin—sarcoma	0.000114	0.000316	CcSEcCtD
Celecoxib—Hypersensitivity—Doxorubicin—sarcoma	0.000114	0.000315	CcSEcCtD
Celecoxib—Asthenia—Doxorubicin—sarcoma	0.000111	0.000307	CcSEcCtD
Celecoxib—Dizziness—Epirubicin—sarcoma	0.000111	0.000305	CcSEcCtD
Celecoxib—Pruritus—Doxorubicin—sarcoma	0.000109	0.000302	CcSEcCtD
Celecoxib—Vomiting—Epirubicin—sarcoma	0.000106	0.000294	CcSEcCtD
Celecoxib—Diarrhoea—Doxorubicin—sarcoma	0.000106	0.000292	CcSEcCtD
Celecoxib—Rash—Epirubicin—sarcoma	0.000105	0.000291	CcSEcCtD
Celecoxib—Dermatitis—Epirubicin—sarcoma	0.000105	0.000291	CcSEcCtD
Celecoxib—Headache—Epirubicin—sarcoma	0.000105	0.000289	CcSEcCtD
Celecoxib—Dizziness—Doxorubicin—sarcoma	0.000102	0.000283	CcSEcCtD
Celecoxib—Nausea—Epirubicin—sarcoma	9.93e-05	0.000274	CcSEcCtD
Celecoxib—Vomiting—Doxorubicin—sarcoma	9.83e-05	0.000272	CcSEcCtD
Celecoxib—Rash—Doxorubicin—sarcoma	9.75e-05	0.000269	CcSEcCtD
Celecoxib—Dermatitis—Doxorubicin—sarcoma	9.74e-05	0.000269	CcSEcCtD
Celecoxib—Headache—Doxorubicin—sarcoma	9.69e-05	0.000268	CcSEcCtD
Celecoxib—Nausea—Doxorubicin—sarcoma	9.18e-05	0.000254	CcSEcCtD
Celecoxib—PDPK1—Immune System—PDGFRB—sarcoma	8.34e-05	0.000226	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—HRAS—sarcoma	8.29e-05	0.000224	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—MDM2—sarcoma	8.27e-05	0.000224	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	8.23e-05	0.000223	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—PDGFRA—sarcoma	8.21e-05	0.000222	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—EGFR—sarcoma	8.21e-05	0.000222	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	8.13e-05	0.00022	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—KRAS—sarcoma	7.98e-05	0.000216	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—sarcoma	7.96e-05	0.000215	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—SRC—sarcoma	7.95e-05	0.000215	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—MDM2—sarcoma	7.85e-05	0.000213	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PLCG1—sarcoma	7.85e-05	0.000212	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—KRAS—sarcoma	7.75e-05	0.00021	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—FLT1—sarcoma	7.75e-05	0.00021	CbGpPWpGaD
Celecoxib—PDPK1—Disease—FOXO1—sarcoma	7.72e-05	0.000209	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PDGFRB—sarcoma	7.7e-05	0.000209	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFC—sarcoma	7.68e-05	0.000208	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—NRAS—sarcoma	7.65e-05	0.000207	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PLCG1—sarcoma	7.62e-05	0.000206	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PDGFRA—sarcoma	7.58e-05	0.000205	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	7.57e-05	0.000205	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—sarcoma	7.52e-05	0.000204	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—SRC—sarcoma	7.52e-05	0.000204	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—JUN—sarcoma	7.49e-05	0.000203	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—SRC—sarcoma	7.46e-05	0.000202	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—FOXO1—sarcoma	7.46e-05	0.000202	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—HRAS—sarcoma	7.46e-05	0.000202	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PDGFRB—sarcoma	7.45e-05	0.000202	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CTNNB1—sarcoma	7.43e-05	0.000201	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	7.41e-05	0.000201	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—HRAS—sarcoma	7.33e-05	0.000199	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PDGFRA—sarcoma	7.33e-05	0.000198	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—VEGFA—sarcoma	7.32e-05	0.000198	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCR4—sarcoma	7.32e-05	0.000198	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—JUN—sarcoma	7.27e-05	0.000197	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—VEGFA—sarcoma	7.26e-05	0.000197	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ATF1—sarcoma	7.24e-05	0.000196	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—NRAS—sarcoma	7.18e-05	0.000194	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—MYC—sarcoma	7.11e-05	0.000193	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	7e-05	0.000189	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—KDR—sarcoma	6.99e-05	0.000189	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—sarcoma	6.97e-05	0.000189	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—EGFR—sarcoma	6.96e-05	0.000188	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	6.92e-05	0.000188	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—sarcoma	6.89e-05	0.000187	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—HRAS—sarcoma	6.85e-05	0.000186	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—HRAS—sarcoma	6.79e-05	0.000184	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—SRC—sarcoma	6.72e-05	0.000182	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CREB1—sarcoma	6.64e-05	0.00018	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	6.59e-05	0.000178	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—NRAS—sarcoma	6.46e-05	0.000175	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—SRC—sarcoma	6.45e-05	0.000175	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—KIT—sarcoma	6.37e-05	0.000173	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—VEGFA—sarcoma	6.35e-05	0.000172	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—sarcoma	6.35e-05	0.000172	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PTPRC—sarcoma	6.26e-05	0.000169	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	6.22e-05	0.000168	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—NRAS—sarcoma	6.2e-05	0.000168	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—KRAS—sarcoma	6.18e-05	0.000167	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CREB1—sarcoma	6.13e-05	0.000166	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PLCG1—sarcoma	6.12e-05	0.000166	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—SRC—sarcoma	6.12e-05	0.000166	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CREB1—sarcoma	6.06e-05	0.000164	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PLCG1—sarcoma	6.03e-05	0.000163	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	6.03e-05	0.000163	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	6.02e-05	0.000163	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	5.97e-05	0.000162	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TLE1—sarcoma	5.97e-05	0.000162	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—NRAS—sarcoma	5.89e-05	0.000159	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—EGFR—sarcoma	5.89e-05	0.000159	CbGpPWpGaD
Celecoxib—PDPK1—Disease—KIT—sarcoma	5.88e-05	0.000159	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—sarcoma	5.84e-05	0.000158	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ATF1—sarcoma	5.82e-05	0.000158	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP2—sarcoma	5.7e-05	0.000154	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—KIT—sarcoma	5.68e-05	0.000154	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF1R—sarcoma	5.68e-05	0.000154	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—EGFR—sarcoma	5.65e-05	0.000153	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	5.6e-05	0.000152	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CREB1—sarcoma	5.6e-05	0.000152	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—KRAS—sarcoma	5.56e-05	0.000151	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—sarcoma	5.49e-05	0.000149	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TLE1—sarcoma	5.45e-05	0.000148	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CREB1—sarcoma	5.41e-05	0.000147	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—FOXO1—sarcoma	5.4e-05	0.000146	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—IL2—sarcoma	5.4e-05	0.000146	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	5.4e-05	0.000146	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PDGFRB—sarcoma	5.4e-05	0.000146	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—EGFR—sarcoma	5.36e-05	0.000145	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—KRAS—sarcoma	5.34e-05	0.000145	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PDGFRA—sarcoma	5.31e-05	0.000144	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	5.26e-05	0.000142	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—HRAS—sarcoma	5.25e-05	0.000142	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL2—sarcoma	5.07e-05	0.000137	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—KRAS—sarcoma	5.07e-05	0.000137	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFC—sarcoma	5.04e-05	0.000136	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—MDM2—sarcoma	5.02e-05	0.000136	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NPM1—sarcoma	4.91e-05	0.000133	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL2—sarcoma	4.91e-05	0.000133	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	4.84e-05	0.000131	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—sarcoma	4.8e-05	0.00013	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	4.73e-05	0.000128	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—HRAS—sarcoma	4.73e-05	0.000128	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MDM2—sarcoma	4.63e-05	0.000125	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HRAS—sarcoma	4.54e-05	0.000123	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL2—sarcoma	4.48e-05	0.000121	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MDM2—sarcoma	4.48e-05	0.000121	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KDR—sarcoma	4.47e-05	0.000121	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	4.47e-05	0.000121	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	4.45e-05	0.000121	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL2—sarcoma	4.44e-05	0.00012	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—SRC—sarcoma	4.43e-05	0.00012	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CTNNB1—sarcoma	4.37e-05	0.000118	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—JUN—sarcoma	4.36e-05	0.000118	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—FOXO1—sarcoma	4.34e-05	0.000118	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PDGFRB—sarcoma	4.34e-05	0.000117	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CTNNB1—sarcoma	4.33e-05	0.000117	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—VEGFA—sarcoma	4.31e-05	0.000117	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—HRAS—sarcoma	4.31e-05	0.000117	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PDGFRA—sarcoma	4.27e-05	0.000116	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NRAS—sarcoma	4.26e-05	0.000115	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ENO2—sarcoma	4.26e-05	0.000115	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KIT—sarcoma	4.12e-05	0.000112	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—NRAS—sarcoma	4.12e-05	0.000112	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FLT1—sarcoma	4.03e-05	0.000109	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CTNNB1—sarcoma	4e-05	0.000108	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	3.97e-05	0.000108	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PLCG1—sarcoma	3.96e-05	0.000107	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—SRC—sarcoma	3.95e-05	0.000107	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CREB1—sarcoma	3.92e-05	0.000106	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—SRC—sarcoma	3.91e-05	0.000106	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—JUN—sarcoma	3.89e-05	0.000105	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	3.89e-05	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—SRC—sarcoma	3.88e-05	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CTNNB1—sarcoma	3.86e-05	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—VEGFA—sarcoma	3.85e-05	0.000104	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCR4—sarcoma	3.8e-05	0.000103	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—NRAS—sarcoma	3.8e-05	0.000103	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	3.79e-05	0.000103	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—VEGFA—sarcoma	3.78e-05	0.000102	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NRAS—sarcoma	3.76e-05	0.000102	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ATF1—sarcoma	3.76e-05	0.000102	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EGFR—sarcoma	3.75e-05	0.000102	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NRAS—sarcoma	3.73e-05	0.000101	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—KRAS—sarcoma	3.67e-05	9.93e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SRC—sarcoma	3.61e-05	9.78e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PLCG1—sarcoma	3.61e-05	9.78e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ENO2—sarcoma	3.56e-05	9.65e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—KRAS—sarcoma	3.54e-05	9.6e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HBA1—sarcoma	3.54e-05	9.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—SRC—sarcoma	3.49e-05	9.45e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NRAS—sarcoma	3.47e-05	9.41e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CXCR4—sarcoma	3.47e-05	9.4e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EGFR—sarcoma	3.46e-05	9.38e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EGFR—sarcoma	3.43e-05	9.28e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—NRAS—sarcoma	3.36e-05	9.09e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KIT—sarcoma	3.31e-05	8.96e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—KRAS—sarcoma	3.27e-05	8.86e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—sarcoma	3.26e-05	8.82e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MDM2—sarcoma	3.24e-05	8.78e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—KRAS—sarcoma	3.24e-05	8.77e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MYC—sarcoma	3.24e-05	8.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—KRAS—sarcoma	3.21e-05	8.69e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EGFR—sarcoma	3.17e-05	8.57e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CREB1—sarcoma	3.15e-05	8.53e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—HRAS—sarcoma	3.12e-05	8.44e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EGFR—sarcoma	3.06e-05	8.28e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PLCG1—sarcoma	3.02e-05	8.19e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HRAS—sarcoma	3.01e-05	8.16e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—KRAS—sarcoma	2.99e-05	8.1e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1R—sarcoma	2.95e-05	7.99e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2—sarcoma	2.9e-05	7.85e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—KRAS—sarcoma	2.89e-05	7.83e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ENO2—sarcoma	2.88e-05	7.81e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HBA1—sarcoma	2.87e-05	7.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—sarcoma	2.85e-05	7.73e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCND1—sarcoma	2.83e-05	7.65e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—JUN—sarcoma	2.82e-05	7.63e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FOXO1—sarcoma	2.81e-05	7.61e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PDGFRB—sarcoma	2.8e-05	7.59e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CTNNB1—sarcoma	2.8e-05	7.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—HRAS—sarcoma	2.78e-05	7.53e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PDGFRA—sarcoma	2.76e-05	7.47e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HRAS—sarcoma	2.75e-05	7.45e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HRAS—sarcoma	2.73e-05	7.39e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MDM2—sarcoma	2.61e-05	7.06e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FOXO1—sarcoma	2.56e-05	6.94e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PDGFRB—sarcoma	2.56e-05	6.93e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HRAS—sarcoma	2.54e-05	6.88e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SRC—sarcoma	2.53e-05	6.85e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PDGFRA—sarcoma	2.52e-05	6.82e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—sarcoma	2.46e-05	6.67e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HRAS—sarcoma	2.46e-05	6.65e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PLCG1—sarcoma	2.45e-05	6.63e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NRAS—sarcoma	2.43e-05	6.59e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ENO2—sarcoma	2.38e-05	6.45e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HBA1—sarcoma	2.37e-05	6.41e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ENO2—sarcoma	2.36e-05	6.39e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HBA1—sarcoma	2.35e-05	6.35e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2—sarcoma	2.33e-05	6.31e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KDR—sarcoma	2.32e-05	6.29e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2—sarcoma	2.3e-05	6.22e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MYC—sarcoma	2.27e-05	6.14e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—JUN—sarcoma	2.27e-05	6.14e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CTNNB1—sarcoma	2.25e-05	6.09e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—sarcoma	2.22e-05	6e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KIT—sarcoma	2.14e-05	5.8e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KRAS—sarcoma	2.09e-05	5.67e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CREB1—sarcoma	2.04e-05	5.52e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—SRC—sarcoma	2.03e-05	5.5e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLCG1—sarcoma	2.02e-05	5.47e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SRC—sarcoma	2e-05	5.43e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLCG1—sarcoma	2e-05	5.42e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NRAS—sarcoma	1.96e-05	5.3e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KIT—sarcoma	1.95e-05	5.29e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—sarcoma	1.95e-05	5.28e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NRAS—sarcoma	1.93e-05	5.22e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—sarcoma	1.86e-05	5.04e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CREB1—sarcoma	1.86e-05	5.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MYC—sarcoma	1.81e-05	4.9e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—sarcoma	1.78e-05	4.82e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRAS—sarcoma	1.78e-05	4.82e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MDM2—sarcoma	1.69e-05	4.56e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KRAS—sarcoma	1.68e-05	4.56e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—KRAS—sarcoma	1.66e-05	4.49e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ENO2—sarcoma	1.56e-05	4.22e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HBA1—sarcoma	1.55e-05	4.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MDM2—sarcoma	1.54e-05	4.16e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2—sarcoma	1.51e-05	4.08e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—sarcoma	1.47e-05	3.99e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCND1—sarcoma	1.47e-05	3.98e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JUN—sarcoma	1.46e-05	3.97e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CTNNB1—sarcoma	1.45e-05	3.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HRAS—sarcoma	1.43e-05	3.87e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HRAS—sarcoma	1.41e-05	3.82e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CTNNB1—sarcoma	1.33e-05	3.59e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLCG1—sarcoma	1.32e-05	3.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SRC—sarcoma	1.31e-05	3.56e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—sarcoma	1.28e-05	3.47e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NRAS—sarcoma	1.26e-05	3.42e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SRC—sarcoma	1.2e-05	3.25e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MYC—sarcoma	1.18e-05	3.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NRAS—sarcoma	1.15e-05	3.12e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—sarcoma	1.15e-05	3.12e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KRAS—sarcoma	1.09e-05	2.95e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MYC—sarcoma	1.07e-05	2.91e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—sarcoma	1.05e-05	2.85e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KRAS—sarcoma	9.93e-06	2.69e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—sarcoma	9.67e-06	2.62e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRAS—sarcoma	9.25e-06	2.5e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HRAS—sarcoma	8.44e-06	2.28e-05	CbGpPWpGaD
